Results 61 to 70 of about 153,485 (203)

Intrauterine Transfusions in Fetuses Affected by Parvovirus B19: Complications, Challenges and Outcomes

open access: yesPrenatal Diagnosis, EarlyView.
ABSTRACT Objective This study evaluates the procedural characteristics, complications, and outcomes of intrauterine transfusion (IUT) for fetal anemia caused by parvovirus B19 infection during the 2023–2024 epidemic in Northwestern Europe. Method This multicenter observational study included all fetuses undergoing IUT for proven parvovirus B19‐induced ...
Banu Özbakir   +6 more
wiley   +1 more source

In Utero HSC Transplantation for Sickle Cell Disease: A Potential Therapeutic Approach That Overcomes Complications of Current Therapies

open access: yesPrenatal Diagnosis, EarlyView.
ABSTRACT Sickle cell disease (SCD) affects millions worldwide but has limited treatment options, most of which carry significant side effects. At present, the only curative treatment for SCD is allogeneic or gene‐modified autologous hematopoietic stem cell (HSC) transplantation (Tx).
Oluwaseun O. Babatunde   +4 more
wiley   +1 more source

Fetal stress hormone changes during intrauterine transfusions

open access: yes, 2011
Item does not contain fulltextOBJECTIVE: To document fetal stress hormone and Doppler changes after intrauterine transfusions (IUTs) in either the intrahepatic portion of the umbilical vein (IHV) or the placental cord insertion (PCI).
R. Wolterbeek   +17 more
core   +1 more source

The pattern of blood loss in adolescent idiopathic scoliosis [PDF]

open access: yes, 2014
Background context Previous studies have shown that modern intraoperative blood-saving techniques dramatically reduce the allogeneic transfusion requirements in surgery for adolescent idiopathic scoliosis (AIS).
Patel, Davandra   +4 more
core   +1 more source

Intrauterine Transfusion for Parvovirus B19–Related Fetal Anemia: A Comparative Cohort Study of Hydropic and Non-Hydropic Outcomes

open access: yesVan Tıp Dergisi
INTRODUCTION: To evaluate the efficacy and safety of intrauterine transfusion (IUT) in fetuses with parvovirus B19–related anemia, and to compare prenatal, procedural, and neonatal outcomes between hydropic and non-hydropic presentations.
Ruken Dayanan   +4 more
doaj   +1 more source

You may need a blood transfusion

open access: yes, 2021
This leaflet is designed to help you and your family understand what a blood transfusion is and how you can help make this a safer treatment for you. Your doctor or nurse will explain if you are likely to need a blood transfusion and why. They will
National Transfusion Advisory Group (NATG)
core  

Maternal and perinatal outcomes associated with prophylactic erythrocytapheresis in pregnant women with sickle cell disease

open access: yes
International Journal of Gynecology &Obstetrics, EarlyView.
Pedro Junqueira Fleury Silva   +12 more
wiley   +1 more source

Neuroimaging Findings and Risk Factors for Brain Injury in Foetuses Treated for Anaemia

open access: yesPrenatal Diagnosis, EarlyView.
ABSTRACT Objective Characterize neuroimaging findings in foetuses with anaemia and identify associated risk factors. Methods Retrospective cohort study of pregnancies with foetal anaemia (defined as haemoglobin > 2 standard deviations below the gestational age mean) confirmed by foetal blood sampling (FBS) and treated with intrauterine transfusion (IUT)
Laurence Sophie Carmant   +6 more
wiley   +1 more source

Parvovirus: Conservative management of fetal anemia and hydrops

open access: yesActa Obstetricia et Gynecologica Scandinavica
Following the COVID‐19 pandemic, Northwestern Europe has experienced a marked increase in congenital parvovirus infections. This rise is attributed to social distancing measures which disrupted the usual seasonal variation of parvovirus B19.
Lyndsay Creswell   +8 more
doaj   +1 more source

The Diagnosis and Prenatal Management of Non‐RHD Alloimmunizations

open access: yesPrenatal Diagnosis, EarlyView.
ABSTRACT Red blood cell (RBC) alloimmunization remains a relevant cause of hemolytic disease of the fetus and newborn (HDFN). Although RhD immunization has significantly decreased since the implementation of systematic prophylaxis, it is still the main cause of alloimmunization in pregnancy.
Mar Bennasar, Antoni Borrell
wiley   +1 more source

Home - About - Disclaimer - Privacy